Using blood treosulfan concentrations to reduce toxicity and improve outcome in children undergoing stem cell transplantation.
Phase of Trial: Phase IV
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Treosulfan (Primary)
- Indications Haemoglobinopathies; Immunodeficiency disorders; Inborn error metabolic disorders; Malignant melanoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 27 Apr 2017 Planned End Date changed from 16 Oct 2018 to 16 Oct 2023.
- 27 Jan 2015 New trial record